MedPath

Safety and effectiveness of microwave ablation (MWA)as a new thermal ablation technique for lungmalignancies (SAMANTHA)

Not Applicable
Conditions
C78.0
C34
Secondary malignant neoplasm of lung
Malignant neoplasm of bronchus and lung
Registration Number
DRKS00007163
Lead Sponsor
Otto-von-Guericke-Universität MagdeburgMedizinische Fakultät
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

1. Primary lung cancer (NSCLC)
o Functional irresectable
•FEV1 < 30% and/or
•diffusion capacity <30% and/or
•mx. O2-uptake in spiro-ergometry < 15% and/or
•EF<30% in echocardiography
and/or
oRefusal of surgical treatment by patient
and/or
oInterdisciplinary decision for microablative treatment

2. Secondary lung malignancies
oInterdisciplinary decision for microablative treatment

- Age > 18 years
- Tumor size between 5mm and 50mm
- Positive proof of vitality:
oFDG-uptake in FDG-PET-CT (positive biopsy needed in case of doubts in a positive PET finding in interdisciplinary consensus)
and/or
osize increase of target lesion in CT
and/or
opositive biopsy of the target lesion
- Distance between target lesion and heart > 20mm

Exclusion Criteria

- Life expectancy <13 month
- Contraindications for a CT-guided intervention
- Contraindications for a microwave ablation
- Abnormal bleeding parameters (PTT < 50%; platelet count < 50x109/L)
- Respiratory insufficiency (pO2 < 60 or pCO2 > 45)
- Myocardial infarction or stroke within 2 month before intervention

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint of the study is the safety of microwave ablation (MWA) of lung malignancies up to 5cm size.
Secondary Outcome Measures
NameTimeMethod
local control after MWA after 4 months (PET-CT) and 13 months (CT)<br>local control after MWA of lung tumors in direct contact with vessels, measuring 3mm or larger<br>characteristics of CT imaging and PET-CT follow-up after MWA<br>local tumor control in association to COPD
© Copyright 2025. All Rights Reserved by MedPath